Bone Biologics Corp (BBLGW) Operating Expenses (2010 - 2025)
Bone Biologics (BBLGW) posted quarterly Operating Expenses of $733105.0 for Q4 2025, down 52.85% year-over-year from $1.6 million in Q4 2024, and up 2.49% quarter-over-quarter from $715274.0 in Q3 2025.
Bone Biologics Corp (BBLGW) Operating Expenses (2010 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported Operating Expenses for 16 consecutive years, with $733105.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses fell 52.85% year-over-year to $733105.0; the TTM figure through Dec 2025 stood at $3.2 million (down 23.33% YoY), while the FY2025 annual figure was $3.2 million, down 23.33% from the prior year.
- Operating Expenses rose to $733105.0 in Q4 2025 per BBLGW's latest filing, from $715274.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $3.1 million in Q1 2023 and bottomed at $180924.0 in Q1 2021.
- Historically, Operating Expenses has averaged $1.1 million across 5 years, with a median of $856600.5 in 2024.
- Annual changes were most pronounced in 2023 — Operating Expenses soared 547.74% — and 2024, when it plunged 73.37%.
- Bone Biologics' Operating Expenses stood at $460482.0 in 2021, then jumped by 179.51% to $1.3 million in 2022, then retreated by 9.87% to $1.2 million in 2023, then surged by 34.05% to $1.6 million in 2024, then slumped by 52.85% to $733105.0 in 2025.
- Business Quant data shows BBLGW's Operating Expenses at $733105.0 in Q4 2025, $715274.0 in Q3 2025, and $748075.0 in Q2 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 733,105.00 |
| Sep 30, 2025 | 715,274.00 |
| Jun 30, 2025 | 748,075.00 |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 951,021.00 |
| Jun 30, 2024 | 809,665.00 |
| Mar 31, 2024 | 903,536.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 469,304.00 |
| Mar 31, 2022 | 689,499.00 |
| Dec 31, 2021 | 460,482.00 |
| Sep 30, 2021 | 229,789.00 |
| Jun 30, 2021 | 231,881.00 |
| Mar 31, 2021 | 180,924.00 |